The dispute stems from a November 2020 vote, when the Council of the EU adopted a resolution supporting changes to the UN’s classification of drugs and psychotropic substances.
Hungary opposed the resolution and issued a separate declaration, prompting the European Commission to sue for breaching the EU’s exclusive rights and undermining the council’s resolution.
In its ruling, the court sided with the EC, stating that Hungary had failed to uphold its obligations under EU law.
It affirmed the EU’s exclusive right to adopt a unified position on such matters and said the principle of loyal cooperation requires member states to support the union’s objectives and refrain from actions that could jeopardize them.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
